Novo Nordisks Wegovy launches in China, offering obesity drug at a fraction of US prices
| SHPCX Fund | USD 13.90 0.03 0.22% |
Slightly above 55% of Health Biotchnology's investor base is interested to short. The analysis of overall sentiment of trading Health Biotchnology Portfolio mutual fund suggests that many investors are impartial at this time. Health Biotchnology's investing sentiment can be driven by a variety of factors including economic data, Health Biotchnology's earnings reports, geopolitical events, and overall market trends.
Health |
The medication is currently available in 16 other countries
Read at finance.yahoo.com
 |
Health Biotchnology Fundamental Analysis
We analyze Health Biotchnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Biotchnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Biotchnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Health Biotchnology is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Health Biotchnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Health Biotchnology mutual fund to make a market-neutral strategy. Peer analysis of Health Biotchnology could also be used in its relative valuation, which is a method of valuing Health Biotchnology by comparing valuation metrics with similar companies.
Peers
Health Biotchnology Related Equities
| VOLMX | Volumetric Fund | 0.34 | ||||
| TQAAX | T Rowe | 0.32 | ||||
| CPUCX | Aam Select | 0.32 | ||||
| WRLDX | Scharf Global | 0.24 | ||||
| ABVCX | Ab Value | 0.1 | ||||
| TWBIX | Balanced Fund | 0.1 |
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |